fbpx What are patients’ goals when initiating long-acting injectable buprenorphine treatment for opioid use disorder? Findings from a longitudinal qualitative study | NDARC - National Drug and Alcohol Research Centre

What are patients’ goals when initiating long-acting injectable buprenorphine treatment for opioid use disorder? Findings from a longitudinal qualitative study

image - 2023 NDARC Webinar Series Web Banner %28Instagram Post %28Square%29%29 1 6
Resource Type: NDARC Seminars

Jo Neale presented at the NDARC Webinar Series on Thursday 23 November.

 

About this webinar

This presentation explored the goals that patients initiating long-acting injectable buprenorphine (LAIB) treatment for opioid use disorder want to achieve and discussed the findings with reference to current UK policy.

 

About the speaker

Jo Neale is a Professor of Addictions Qualitative Research based within the National Addiction at the Institute of Psychiatry, Psychology & Neuroscience, King’s College London, UK. She is also a Conjoint Professor in the Centre for Social Research in Health at UNSW Sydney, Australia. Jo trained in social work and has conducted qualitative research on topics including homelessness, drug treatment effectiveness, opioid overdose, substance use and sleep, and online and app-based interventions for substance use disorder. She is currently Senior Qualitative Editor of the journals “Addiction” and the “International Journal of Drug Policy”.